Skip to main content
. 2019 Sep 20;14(9):e0222102. doi: 10.1371/journal.pone.0222102

Fig 2. Shunt occlusion rate within 2 years after the start of hemodialysis in patients with thrombophilic risk factors (TRFs) compared to patients without a thrombophilic defect (no TRF).

Fig 2

(A) Data of all patients with TRFs (TRF), those with 1 TRF (1 TRF), and those with multiple TRFs (>1 TRF) are shown. *P<0.05 by Fisher’s exact test and chi-square test vs. no TRF; n.s., Fisher’s exact test P>0.05. (B) Shunt occlusion rate for the respective TRFs exclusively (dark bars) or combined with at least 1 further TRF (light bars). Factor V, factor V Leiden mutation; MTHFR, MTHFR mutation; APL-Abs, antiphospholipid antibodies; Prot. C/S, protein S/protein C deficiency; AT-def., AT deficiency; Prothromb. Mut., 20210G>A mutation of the prothrombin gene.